Globus Medical, Inc.
GMED
$52.64
$0.010.02%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.52B | 2.48B | 2.24B | 1.90B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.51B | 2.52B | 2.48B | 2.24B | 1.90B |
| Cost of Revenue | 827.58M | 819.91M | 816.69M | 742.30M | 612.43M |
| Gross Profit | 1.68B | 1.70B | 1.66B | 1.49B | 1.29B |
| SG&A Expenses | 974.69M | 977.44M | 968.77M | 884.49M | 766.49M |
| Depreciation & Amortization | 118.50M | 119.37M | 117.58M | 101.27M | 76.11M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.06B | 2.08B | 2.08B | 1.90B | 1.61B |
| Operating Income | 451.25M | 441.03M | 395.05M | 333.45M | 284.72M |
| Income Before Tax | 232.95M | 120.72M | 121.05M | 66.55M | 93.65M |
| Income Tax Expenses | 47.39M | 17.74M | 29.54M | 25.88M | 27.02M |
| Earnings from Continuing Operations | 185.56 | 102.98 | 91.51 | 40.68 | 66.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 185.56M | 102.98M | 91.51M | 40.68M | 66.63M |
| EBIT | 451.25M | 441.03M | 395.05M | 333.45M | 284.72M |
| EBITDA | 716.15M | 695.19M | 652.14M | 560.98M | 466.75M |
| EPS Basic | 1.36 | 0.76 | 0.67 | 0.30 | 0.64 |
| Normalized Basic EPS | 1.97 | 1.82 | 1.84 | 1.57 | 1.52 |
| EPS Diluted | 1.34 | 0.75 | 0.66 | 0.29 | 0.63 |
| Normalized Diluted EPS | 1.93 | 1.80 | 1.82 | 1.56 | 1.50 |
| Average Basic Shares Outstanding | 544.30M | 542.90M | 544.05M | 521.97M | 487.15M |
| Average Diluted Shares Outstanding | 554.53M | 550.11M | 549.42M | 526.60M | 491.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |